Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Tax Provisions (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Tax Provisions for 9 consecutive years, with $172000.0 as the latest value for Q1 2026.

  • For Q1 2026, Tax Provisions rose 115.64% year-over-year to $172000.0; the TTM value through Mar 2026 reached $1.5 million, up 126.45%, while the annual FY2025 figure was $200000.0, 104.17% up from the prior year.
  • Tax Provisions hit $172000.0 in Q1 2026 for Bicycle Therapeutics, down from $1.3 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $2.3 million in Q3 2023 and bottomed at -$3.4 million in Q3 2024.
  • Average Tax Provisions over 5 years is -$255352.9, with a median of -$400000.0 recorded in 2022.
  • Year-over-year, Tax Provisions skyrocketed 1236.0% in 2023 and then tumbled 407.71% in 2024.
  • Bicycle Therapeutics' Tax Provisions stood at -$400000.0 in 2022, then skyrocketed by 190.75% to $363000.0 in 2023, then crashed by 407.71% to -$1.1 million in 2024, then surged by 217.55% to $1.3 million in 2025, then crashed by 86.9% to $172000.0 in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $172000.0, $1.3 million, and $205000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.